Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma [Internet].

To assess efficacy of intermittent inhaled corticosteroid (ICS) therapy in different populations (0 to 4 years old with recurrent wheezing, 5 years and older with persistent asthma, with or without long-acting beta agonist [LABA]), and to assess efficacy of added long-acting muscarinic antagonist (LAMA) in patients 12 years and older with uncontrolled, persistent asthma.

https://ift.tt/2IxGw47